The broad-spectrum inhibitor of PKC (Bisindolylmaleimide I) and inhibitor of PKCα and PKCβ (Gö6976) could reduce the Erastin-induced ferroptosis of rhabdomyosarcoma cells [14]. The gene discussed is PRRT2; the disease is rhabdomyosarcoma.